Supernus Fair Value
SU
The fair market value of SUPN stock is 29.14 USD. Relative to the market price of 35.82 USD Supernus is overvalued by 18.7%
Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.
Fair Relative Value
Supernus Valuation
Current SUPN share ticker price is 35.82 USD.
The fair value level of 29.14 USD can be considered as an effective entry point for long-term investors to start investing in SUPN stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.
Price chart is not available
Current market price
Current price is 19% higher its fair value
Current price is 68% higher its minimum value
Current price is 63% lower its maximum value
Market price:
SUPN stock is overvalued
It means the current price may concern as a Risky Entry Point
Supernus Pharmaceuticals Inc Stock Valuation Calculator
How do we value a stock?
As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.
1
Maximum P/E over 5 years
53.73
2
Median P/E over 5 years
26.86
3
Minimum P/E over 5 years
10.52
4
Earning per share (last 12 months)
1.08 USD
Maximum value
1
x
4
=
58.28 USD
Fair value
2
x
4
=
29.14 USD
Minimum value
3
x
4
=
11.41 USD
Supernus Pharmaceuticals Inc price metrics
10.06
Annual return (geometric mean)
41.68
Risk (standard deviation) of returns
β
0.89
Beta (volatility compared to market)